New hope for kids with tough kidney disease: obinutuzumab may replace steroids

This study tests a new drug called obinutuzumab in 100 children aged 1-18 with refractory nephrotic syndrome, a kidney condition causing swelling and protein loss. The drug targets immune cells to reduce disease flares and dependence on steroids and other medications. Researchers aim to see if it works better than an older similar drug (rituximab) and helps more children achieve remission.